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T
 
he paradigm that DNA is the central bank of genetic in-
formation within the cell, and that portions of the DNA
are copied via transcription to RNA, which is subsequently
decoded to synthesize protein in a cell, is basically true
throughout cellular evolution. However, it is also true that
although this is a general blueprint for regulating how genes
are expressed, evolution, with its varied selective pressures,
has allowed organisms to develop many different mechanisms
for regulating gene expression. As a consequence, a plethora
of novel regulatory schemes from bacteria to mammalian
cells has been described. Organisms with constraints on ge-
nome size have used novel genetic tricks to both regulate
gene expression and synthesize multiple proteins from a
single gene. However, in higher eucaryotes, the common
perception is that genome size is not an issue, and that genes
will typically
 
 
 
be far apart from each other and can be regu-
lated by independent control mechanisms.
Although genes in mammalian cells are generally sepa-
rated by large chunks of DNA, the paper by Van den Eynde
and colleagues in this issue (1) demonstrates that this is not
always the case. What started off as a project to isolate a tu-
mor-specific antigen from a renal carcinoma cell led to the
discovery of a protein product that is encoded within an-
other gene from its antisense strand (Fig. 1). The project
began by isolating a clone of a CTL from a kidney cancer
patient that responded to tumor cells. A cDNA library pre-
pared with RNA from the renal tumor cells was trans-
fected, along with HLA-B7 gene, into COS cells. A cDNA
was isolated that was able to stimulate the CTL cells. Fur-
ther analysis indicated that the transcript should be 
 
z
 
1.4 kb
in size. Surprisingly, however, the transcript migrated as a
2.2-kb mRNA on a Northern blot. This paradox was re-
solved when Van den Eynde and colleagues characterized
additional cDNA clones from this library. Unexpectedly,
these results led to the discovery that the tumor-specific an-
tigen was not encoded within the open reading frame of
this gene. Rather, it resided within this gene but initiated
its transcription within its first intron and synthesized the
RNA from the complementary (or antisense) strand of this
gene (Fig. 1). The authors named the gene encoding the
2.2-kb RNA band RU2S, while the gene encoding the tu-
mor-specific antigen transcribed in the opposite direction
was called RU2AS. The RU2S transcript appears to en-
code a housekeeping mRNA, since it is expressed in all tis-
sues examined and the presence of CpG islands within the
promoter and first exon are also consistent with this notion.
On the other hand, the antisense RU2AS mRNA was re-
stricted to expression in the kidney, bladder, liver, and testis,
yet interestingly, RU2AS was expressed in a large number of
tumor cells.
These results are striking for a number of reasons. Clearly,
they demonstrate that mammalian genes do not have to be
separated from each other by significant amounts of DNA.
These results also demonstrate that the antisense strand of
one gene can be transcribed and encode a protein product.
Although there are several examples of noncoding RNAs
that are involved in regulating gene expression in both
prokaryotes and eukaryotes (for a review, see reference 2),
examples in which antisense RNAs encode a protein have
been rare, having only been observed in viruses such as
 
herpes simplex virus (HSV) adenovirus, and HIV (2–5). It is
not surprising that viruses, with compact genomes, will use
both strands to encode genetic information, allowing them
to maximize the relative amount of information they can
transfer. In the cases of herpes virus and adenovirus, the an-
tisense RNAs do not seem to have a regulatory function
since they are expressed at different stages in the virus life
cycle, so their expression is temporally separated within an
infected cell. This leads to an interesting question that has
yet to be addressed, namely does the RU2AS RNA and
not the protein product have a regulatory role in control-
ling gene expression? Does it also function as an antisense
RNA to regulate the expression of the RU2S mRNA?
Does the RU2AS protein product have a regulatory role in
controlling the expression of the RU2S transcript? Or, possi-
bly, they are not functionally related. They might represent
remnants of a viral infection and evolved to have different
functions. It is not likely that expression of RU2AS is to
signal antitumor CTLs for killing. These questions will await
further analysis of the role of the RU2SA protein product
in cells and how this protein product is regulated.
The RU2AS transcript has an attribute that makes it
unique compared with most other cellular mRNAs. The
RU2AS transcript lacks intron sequences. This is an unusual
scenario in mammalian cells, since removal of the last in-
tron correlates with efficient polyadenylation (6, 7). Fur-
thermore, the splicing process has also been linked to effi-
cient export of RNAs from the nucleus to the cytoplasm
(see 6–8). In fact, viruses, in particular retroviruses and cel-
lular mRNAs that lack introns, have evolved specialized se-
quences that promote efficient cytoplasmic transport of un-
spliced RNAs. For example, the retrovirus Mason-Pfizer 
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monkey virus (9) and the HSV thymidine kinase gene (10)
have been shown to contain a cytoplasmic transport ele-
ment (CTE) that binds to known RNA binding proteins
and promotes transport of these mRNAs into the cytoplasm
in which they are subsequently translated. The lentivirus
family of retroviruses exemplified by HIV-1 has evolved so
that it encodes its own RNA transport machinery within
its genome. The HIV RNA not only encodes a cis-acting
element, 
 
rre
 
, but also encodes the Rev protein that interacts
in trans with this sequence, ensuring efficient export of the
unspliced and singly spliced HIV-1 RNAs (11). Based on
these observations, it would be anticipated that the intron-
less RU2AS transcript would also encode a CTE that would
allow it to be exported and translated.
The results in Van den Eynde et al. (1) describe an inter-
esting and exciting new system in which there is a gene
within a gene that together are divergently transcribed,
making both Watson and Crick strands of the DNA en-
code both an RNA and a protein. Clearly, there are several
interesting questions that can be addressed using this sys-
tem. It would be appealing to determine whether most of
the RU2AS mRNA is in the cytoplasm or whether it is
predominantly nuclear. This result may begin to shed light
on whether the RU2AS RNA plays a regulatory role mod-
ulating gene expression. In addition, the identification of
the RU2AS CTE may define a novel element that allows
cellular transcripts lacking introns to be transported to the
cytoplasm. It is also intriguing that the RU2AS RNA ap-
pears to be more abundant in cancer cells than in normal
tissues. Perhaps this is a reflection of misregulation of RNAs
lacking introns such that they are more efficiently exported
and stabilized. It is conceivable, although not experimen-
tally tested, that the cellular export machinery is altered in
cancer cells, leading to greater accumulation of these types
of RNAs. Although these investigations are in the early
stages, additional experiments in this area may have consid-
erable impact in both our understanding of RNA biology
and our thinking about how the genome is structured and
expressed.
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